Rosetta Genomics Company Profile (NASDAQ:ROSG)

About Rosetta Genomics

Rosetta Genomics logoRosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). It is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. Its therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. It focuses on developing diagnostic assay, RosettaGX Reveal V2. It is also focusing on developing Bladder cancer risk stratification. Its PersonalizeDx is focused on the detection of genomic changes through FISH technology, which helps to detect cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ROSG
  • CUSIP:
Key Metrics:
  • Previous Close: $1.01
  • 50 Day Moving Average: $1.067
  • 200 Day Moving Average: $1.158
  • 52-Week Range: $0.71 - $3.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.94
  • P/E Growth: -0.100
  • Market Cap: $20.04M
  • Outstanding Shares: 20,852,000
  • Beta: -3.5
Additional Links:
Companies Related to Rosetta Genomics:

Analyst Ratings

Consensus Ratings for Rosetta Genomics (NASDAQ:ROSG) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.33 (243.64% upside)

Analysts' Ratings History for Rosetta Genomics (NASDAQ:ROSG)
Show:
DateFirmActionRatingPrice TargetDetails
6/13/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
3/28/2016AegisReiterated RatingBuy$3.50View Rating Details
3/28/2016Barrington ResearchLower Price TargetOutperform$5.00 -> $3.50View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Rosetta Genomics (NASDAQ:ROSG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
5/19/2016Q116($0.16)($0.18)$3.36 million$2.60 millionViewListenView Earnings Details
3/23/2016Q415($0.33)($0.14)$3.60 millionViewListenView Earnings Details
12/1/2015Q315$0.27$2.43 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rosetta Genomics (NASDAQ:ROSG)
Current Year EPS Consensus Estimate: $-0.65 EPS
Next Year EPS Consensus Estimate: $-0.50 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.17)($0.17)($0.17)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rosetta Genomics (NASDAQ:ROSG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rosetta Genomics (NASDAQ:ROSG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Rosetta Genomics (NASDAQ:ROSG)
DateHeadline
News IconRosetta Genomics Selected by a Global Pharmaceutical Company to Supply FISH Testing Services for Clinical Study in Prostate Cancer (NASDAQ:ROSG)
www.enhancedonlinenews.com - August 24 at 10:15 AM
finanznachrichten.de logoGlobal Biochip Market Worth $18.4 Billion in 2020 - Analysis By Type - Research and Markets (NASDAQ:ROSG)
www.finanznachrichten.de - August 11 at 7:43 PM
News IconRosetta Genomics Expands Molecular Diagnostics Test Menu With Launch Of OncoGxSelect From Admera Health (NASDAQ:ROSG)
www.laboratorynetwork.com - August 5 at 7:26 PM
finance.yahoo.com logoRosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of OncoGxSelect™ from Admera Health (NASDAQ:ROSG)
finance.yahoo.com - August 4 at 10:23 AM
finance.yahoo.com logoRosetta Expands Managed Care Coverage with New Preferred Provider Agreement with Galaxy Health Network for Entire Suite of Diagnostic Tests and Services (NASDAQ:ROSG)
finance.yahoo.com - August 2 at 12:08 PM
investornewswire.com logoExpected For Rosetta Genomics Ltd. (NASDAQ:ROSG) Sales Of $74.285 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - July 29 at 7:20 PM
investornewswire.com logoRosetta Genomics Ltd. (NASDAQ:ROSG) Expected To Post Sales Of $74.285 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - July 24 at 11:15 AM
News IconRosetta Genomics Limited Ord (NASDAQ:ROSG) Shorted Shares Decreased By 2.52% - Consumer Eagle (NASDAQ:ROSG)
www.consumereagle.com - July 18 at 12:44 PM
News IconRosetta Genomics gets US patent for microRNA-based ovarian cancer treatment (NASDAQ:ROSG)
www.pharmabiz.com - July 13 at 7:35 PM
News IconRosetta Genomics Limited Ord (NASDAQ:ROSG) Shorts Decreased by 2.52% After Short Covering - Consumer Eagle (NASDAQ:ROSG)
www.consumereagle.com - July 13 at 10:06 AM
streetinsider.com logoRosetta Genomics (ROSG) Receives USPTO Notice of Allowance on '548 Patent App (NASDAQ:ROSG)
www.streetinsider.com - July 12 at 11:34 AM
publicnow.com logoRosetta Genomics Receives U.S. Patent Allowance for microRNA-based Ovarian Cancer Treatment (NASDAQ:ROSG)
www.publicnow.com - July 11 at 1:23 PM
feeds.benzinga.com logoRosetta Genomics Gets Patent Allowance For microRNA-based Ovarian Cancer Treatment (NASDAQ:ROSG)
feeds.benzinga.com - July 11 at 12:37 PM
streetinsider.com logoRosetta Genomics (ROSG) Receives USPTO Notice of Allowance on '548 Patent App - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - July 11 at 11:49 AM
fiscalstandard.com logoBrokers Issue Average Price Target Of 5.12 On Rosetta Genomics Ltd. (ROSG) - Fiscal Standard (NASDAQ:ROSG)
www.fiscalstandard.com - July 10 at 6:26 PM
fiscalstandard.com logoRosetta Genomics Ltd. (ROSG) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:ROSG)
www.fiscalstandard.com - July 10 at 6:26 PM
News IconRosetta Genomics Limited Ord (NASDAQ:ROSG) Sellers Covered 2.52% of Their Shorts - Engelwood Daily (NASDAQ:ROSG)
www.engelwooddaily.com - July 7 at 7:15 PM
ftsenews.co.uk logoRosetta Genomics Ltd. (ROSG) Updated Price Targets - FTSE News (NASDAQ:ROSG)
www.ftsenews.co.uk - July 7 at 7:15 PM
tmcnet.com logoRosetta Genomics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:ROSG)
www.tmcnet.com - July 6 at 7:31 PM
finance.yahoo.com logoRosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:ROSG)
finance.yahoo.com - July 6 at 8:00 AM
fiscalstandard.com logoBroker Outlook For The Week Ahead Rosetta Genomics Ltd. (ROSG) - Fiscal Standard (NASDAQ:ROSG)
www.fiscalstandard.com - July 5 at 11:37 AM
investornewswire.com logoSales of $74.285 expected for Rosetta Genomics Ltd. (NASDAQ:ROSG) - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - July 2 at 9:51 AM
ftsenews.co.uk logoNew Broker Ratings For Rosetta Genomics Ltd. (ROSG) - FTSE News (NASDAQ:ROSG)
www.ftsenews.co.uk - July 1 at 7:11 PM
investornewswire.com logoRosetta Genomics Ltd. (NASDAQ:ROSG) Yearly Sales Target At $74.285 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - June 24 at 7:17 PM
News IconRosetta Genomics Ltd. (USA) (NASDAQ:ROSG) Completes 50-State Sweep For Its FISH Tests - Scibility Media (NASDAQ:ROSG)
scibilitymedia.com - June 24 at 7:17 PM
streetinsider.com logoRosetta Genomics (ROSG) Wins Conditional New York State Approval for HEME FISH-based Assays (NASDAQ:ROSG)
www.streetinsider.com - June 23 at 9:49 AM
businesswire.com logoRosetta Expands Managed Care Coverage with New Preferred Provider Agreement for Entire Suite of Diagnostic Tests and Services (NASDAQ:ROSG)
www.businesswire.com - June 23 at 9:49 AM
reuters.com logoBRIEF-Rosetta Genomics Ltd announces agreement with Preferred Provider Organization (NASDAQ:ROSG)
www.reuters.com - June 23 at 9:49 AM
4-traders.com logoRosetta Genomics USA : Expands Managed Care Coverage with New Preferred Provider Agreement for Entire Suite of Diagnostic Tests and Services (NASDAQ:ROSG)
www.4-traders.com - June 23 at 9:49 AM
capitalcube.com logoRosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 (NASDAQ:ROSG)
www.capitalcube.com - June 22 at 1:01 PM
benzinga.com logo8 Biggest Mid-Day Gainers For Tuesday - Benzinga (NASDAQ:ROSG)
www.benzinga.com - June 22 at 11:54 AM
streetinsider.com logoRosetta Genomics (ROSG) Wins Conditional New York State Approval for HEME FISH-based Assays - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - June 22 at 11:54 AM
streetupdates.com logoLast Analysts Rating Review: Rosetta Genomics Ltd. (NASDAQ:ROSG) , Medtronic plc (NYSE:MDT) - Street Updates (NASDAQ:ROSG)
www.streetupdates.com - June 22 at 11:54 AM
finance.yahoo.com logoRosetta Genomics Receives Approval from New York State for HEME FISH-based Assays (NASDAQ:ROSG)
finance.yahoo.com - June 21 at 11:29 AM
insidermonkey.com logoHere’s Why These Five Stocks Are Gaining Ground on Tuesday (NASDAQ:ROSG)
www.insidermonkey.com - June 21 at 11:19 AM
investornewswire.com logoRosetta Genomics Ltd. (NASDAQ:ROSG) Yearly Sales Projections At $74.285 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - June 19 at 10:57 AM
kcregister.com logoEnvision Healthcare Holdings, Inc. (NYSE:EVHC) plummeted -6.18%: Rosetta Genomics, Ltd. (NASDAQ:ROSG ... - KC Register (NASDAQ:ROSG)
www.kcregister.com - June 17 at 9:54 AM
investornewswire.com logoCan Rosetta Genomics Ltd. (NASDAQ:ROSG) Keep Up with Analyst Expectations? - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - June 11 at 7:21 PM
News IconBroker Watchlist: Rosetta Genomics Ltd. (ROSG) - Share Trading News (NASDAQ:ROSG)
www.sharetrading.news - June 3 at 10:07 AM
tradecalls.org logoRevenue Update on Rosetta Genomics Ltd. (USA)(NASDAQ:ROSG) - Trade Calls (NASDAQ:ROSG)
www.tradecalls.org - May 27 at 12:59 AM
streetinsider.com logoRosetta Genomics (ROSG) Announces Publication of Positive Thyroid Nodule Classification Assay Data - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - May 26 at 8:06 AM
finance.yahoo.com logoRosetta Genomics Announces Publication of Data Confirming Analytical Validity of its Novel Thyroid Nodule Classification Assay (NASDAQ:ROSG)
finance.yahoo.com - May 26 at 7:00 AM
News IconLatest Analyst Ratings For Rosetta Genomics Ltd. (ROSG) - Share Trading News (NASDAQ:ROSG)
www.sharetrading.news - May 25 at 11:19 AM
streetinsider.com logoRosetta Genomics (ROSG) Announces New York State Approval for Four PCR-Based Assays - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - May 23 at 12:53 PM
finance.yahoo.com logo8:05 am Rosetta Genomics receives conditional approval from the NY State Department of Health for four allele-specific PCR (CAST PCR)-based assays (NASDAQ:ROSG)
finance.yahoo.com - May 23 at 8:05 AM
finance.yahoo.com logoRosetta Genomics Receives Approval from New York State for Four PCR-Based Assays (NASDAQ:ROSG)
finance.yahoo.com - May 23 at 8:00 AM
4-traders.com logoRosetta Genomics USA : Reports 2016 First Quarter Financial Results (NASDAQ:ROSG)
www.4-traders.com - May 20 at 12:53 AM
finance.yahoo.com logoEdited Transcript of ROSG earnings conference call or presentation 19-May-16 2:00pm GMT (NASDAQ:ROSG)
finance.yahoo.com - May 19 at 3:41 PM
publicnow.com logoRosetta Genomics Reports 2016 First Quarter Results (NASDAQ:ROSG)
www.publicnow.com - May 19 at 11:02 AM
finance.yahoo.com logoRosetta Genomics Reports 2016 First Quarter Financial Results (NASDAQ:ROSG)
finance.yahoo.com - May 19 at 8:00 AM

Social

Rosetta Genomics (NASDAQ:ROSG) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff